Objectives: In light of declining numbers of physician-scientists, the goal of this project was to identify strategies to invigorate and attract new talent to clinical research in the field of pediatric neurosciences.
Introduction
Recent changes in the financing of health care have dramatically influenced not only the delivery of health care in our nation, but also the practice of academic medicine and the priorities for medical education. In particular, the role of research in academic medicine has atrophied under increased pressures to maximize patient volume and minimize practice and educational costs. In light of these changes, both the AMA and NIH have voiced growing concerns about the vitality and future of the medical research enterprise, particularly as it relates to the training of future physician-scientists. To directly address these concerns, the American Academy of Pediatrics and the National Institutes of Child Health and Human Development organized a meeting held in Rockville, MD, from 15 to 16 January 2004, to address two main objectives: (1) identify key gaps in basic, translational, and clinical research in neonatology; and (2) address the issue of the dwindling pool of physician-scientists and propose how to rectify the situation in the current setting of clinical practice and academia. This manuscript is a summary of a presentation made at that meeting.
To address the objectives for this conference, the following questions were composed:
What are the key research gaps in your research area? What are the infrastructure/funds/collaborative efforts and workforce needs to facilitate training in your field? How do you identify and train future physician-scientists? How do you identify good mentors for physician-scientists? How do you retain quality researchers in academia for a lifetime career? How do you/can you balance academia and practice pressures?
To develop a broad perspective of these concerns, the above questions were addressed to a variety of physicians and medical scientists at all stages of career development from throughout the US and several different countries ( Table 1) . Selection of the individuals interviewed was based solely on the fact that each was someone familiar to the author and with whom the author had previously interacted in a professional capacity. To preserve a modicum of focus relevant to the training of pediatricians and neonatologists, the panel of individuals surveyed consisted mainly of individuals with neonatal neuroscience expertise. Each of the participating individuals provided responses via either the telephone or e-mail well in advance of the conference, and the responses were then collated and organized to form the presentation given at the conference. Many of the statements offered were given without reference to specific publications, and thus represent opinion and perspective. development vary greatly among different laboratory animal species, and can be very different than observed in human tissues, there is a great need to explore developmental processes in virtually all human tissues. As many human tissues can be obtained routinely, physician-scientists enjoy a unique opportunity to extend findings and mechanisms identified in animal tissues into highly relevant immature human tissues. For example, new applications of microscopic autoradiography with computer-based image analysis make possible the highly sensitive characterization of receptor type and densities, agonist affinity, and antagonist efficacy for numerous receptor systems. 1 Similarly, recently developed micromethods are capable of reliably measuring contractile responses and cytosolic calcium in very small arteries and veins. 2 More generally, the recent exponential growth in the number of high-quality antibodies available commercially (www.antibodyresource.com/) has greatly simplified the use of Western blots and immunohistochemistry to probe for agedependent differences in protein expression and localization. With these new tools, valuable new knowledge and insights into the effects of development and maturation on human tissue structure and function can be gained relatively easily.
Research gaps: cerebral immunology
Another area offering recent technical advances is the field of cerebral immunology. Owing to major improvements in the ability to identify lymphocytes and macrophages using laser flow cytometry, 3 the study of immune function within the central nervous system is attracting growing and unprecedented scientific interest. Other new methods, including the cytometric bead array, 4 enable simultaneous measurement of multiple cytokine signals, such as IL-2, IL-4, IL-6, IL-10, TFNa, and IFNg, all from a single sample. Tools such as these offer a new window into the processes of cerebral inflammation that accompany numerous cerebral insults such as hypoxia and ischemia. 5 This growing field offers many clinically relevant and highly original research opportunities to physician-scientists interested in creatively combining the rapidly expanding fields of developmental immunology and developmental neuroscience. Research gaps: proteomics The momentum created by the Human Genome Project's sequencing of the 30 000 genes that constitute the human genetic repertoire has in turn focused new enthusiasm on the study of the proteins that each of these genes represent. Apparatus enabling preparative electrophoresis and isoelectric focusing is now widely available in many different economical formats and most of these methods facilitate rapid enrichment and purification of target proteins in almost any laboratory setting. 6 A broad variety of chips are now also available with several different technologies enabling protein array assays. To facilitate such investigations, numerous highly useful websites are now produced by commercial, governmental, and private concerns (see Table 2 ). Recent improvements in mass spectrometry methods have made highly accurate quantitative measurements of extremely small amounts of protein feasible for the first time. 7 Given this range of viable proteomic methodologies together with the fact that relatively few proteomic studies have examined immature human tissues, this technology promises to dramatically expand understanding of developmental neuroscience provided that it attracts the interest of significant numbers of physician-scientists newly trained in the fields of pediatrics and neonatology.
Research gaps: nuclear magnetic resonance Within the arena of patient care and diagnosis, one of the most impressive areas of advance is the use of nuclear magnetic resonance (NMR) technology. Nuclear magnetic resonance imaging now offers remarkable sensitivity and ability to resolve fine changes in cerebral structure. A variety of studies suggest, however, that the conditions optimal for NMR imaging are often different in adult and neonatal brains. 8 There is thus a significant need for detailed radiologic investigations focused not only on identifying how healthy cerebral structures change during early postnatal development, but also how pathologic processes differentially affect the immature brain. Similarly, recent improvements in cerebral proton magnetic resonance spectroscopy offer unprecedented opportunities for the noninvasive study of fundamental neurochemistry in the immature brain. 9 This rapidly changing field is in its earliest stages but, when combined with state-of-theart NMR imaging, offers tremendous potential for translational research.
Research gaps: other One additional area in need of clarification is the phenotyping of neonatal brain injury. In particular, we need to understand what factors determine vulnerability, how damage and functional impairment are related, how relevant are current models of ischemia, and how gender influences responses to insults. On the topic of brain development, we need to better understand what controls cell differentiation of cerebral neurons and glia, what influences stem cells to reproduce and migrate, what signals are communicated among different cell types, and how these reflect regionality. We need greater appreciation of the subtleties of changes in neuropharmacological signal transduction pathways during development and maturation. In particular, what are the key pathways and intermediates simultaneously activated by ischemia and hypoxia, which apoptotic processes are amenable to therapeutic manipulation, and to what extent is intercellular communication accessible to pharmacologic intervention? At a more integrative level, we need to better understand how cerebral insults influence systemic, cardiovascular, endocrine, and metabolic homeostasis, how important are given intracellular mechanisms in determining whole organ and whole body responses, and to what extent does regulatory redundancy limit our ability to manipulate mechanisms, in vivo. In terms of bioinformatics, we need to develop predictive models that can integrate genomic, proteomic, organ level, and in vivo findings. Certainly, there is no paucity of interesting, challenging, and clinically relevant problems to pursue. The main question it would seem, is how do we choose what to investigate and when?
Part II: invigorating physician-scientist training in neonatology Although the responses offered by the interviewees listed in Table 1 easily identified numerous promising research topics with great potential to advance understanding of neonatal physiology and pathophysiology, the combined responses also indicated that progress was limited more by the small numbers of well-trained neonatal physician-scientist investigators than by any other factor. When asked how this situation might be improved, the opinions offered varied considerably and focused on both trends in public policy as well as recent changes in the way that physicians are trained. The responses were thus organized into a presentation of ideas related to the changing role of the physician-scientist in translational research, followed by a summary of ideas related to ways medical training might be enhanced to produce greater numbers of productive physician-scientist investigators.
Translational research: a historical perspective Whereas the opportunities and challenges for today's physicianscientists are in many ways unprecedented, some of the more general features of the current climate are simply the extensions of trends recognized many years ago. As has long been the case, the pace of translational research is limited not by a lack of exciting new technologies, nor of critical clinical problems amenable to investigation, but rather by the limited availability of successful, extramurally funded physician-scientists dedicated to identifying the most relevant and promising areas of clinical research and then applying basic research advances to the study of these problems. This point was beautifully articulated more than 20 years ago by Dr James Wyngaarden in his New England Journal of Medicine article entitled 'The Clinical Investigator as an Endangered Species'. 10 This problem has also been visited more recently by NIH staff, and their findings are available on the internet in an article entitled 'Addressing the Nation's Changing Needs for Biomedical and Behavioral Scientists' (http:// grants1.nih.gov/training/nas_report/). One of the key findings to come from these studies is that as recently as 1997, only about one-fifth of all RO-1 grants were awarded to investigators with an MD degree, and of these, many were not actively practicing medicine. Of those MDs engaged in research, most are choosing basic research in favor of clinical research. This result, in turn, is commonly attributed to three main causes: (1) clinical trials are difficult and expensive to implement; (2) many IRBs prioritize minimization of liability exposure over scientific rigor; and (3) basic science investigations are easier to fund. One important consequence of these conditions is that the majority of clinical research is now performed by nonclinician scientists.
Translational research: a specialization perspective To understand the current decline in the numbers of physicianscientists building successful careers in clinical research, it is helpful to examine the major differences in the ways basic scientists and clinicians are trained. Basic scientist researchers are trained to emphasize depth of knowledge and critical thinking. In turn, the key ingredients for basic scientist success include: (1) technical expertise with state-of-the-art methods; (2) mastery of the literature; and (3) creativity and innovation. In contrast, physician-scientist researchers are trained to emphasize breadth of knowledge and integrative thinking. For them, the ingredients for success include: (1) protected time and financial support; (2) successful clinical and basic scientist mentors and collaborators; and (3) technical and administrative infrastructure and support.
Simply put, physician-scientists have a much broader area of knowledge and expertise to master, and far less time to maintain it. Given these constraints, it should be expected that physicianscientists have difficulty securing basic science research support when competing directly with full-time basic scientists who devote all their professional time and training to basic research. The logical alternative, then, would be for physician-scientists to conduct clinical research that can be performed only by investigators with an MD degree and a license to practice. This approach should create a scientific niche in which physicianscientists compete primarily against one another utilizing skills and expertise unique to clinical training. Certainly, this strategy involves numerous challenges and problems, as stated above, but with sustained effort and investment, should constitute a more reliable path to success in clinical and translational research. The question then, is how can institutions build such programs?
Translational research: an international perspective The challenges in building successful clinical research programs are not unique to the US. Indeed, similar pressures have forced a decline in the vitality of clinical research in most industrialized nations, many of which have innovated an impressive variety of approaches to combat decreasing numbers of physician-scientists. In England, for example, major research opportunities exist, but few physicians appear trained to take advantage of them (D Edwards, personal communication, see Table 1 ). The problem is exacerbated because research often advances too fast for practicing clinicians to stay abreast of latest developments, and grant funding for neonatal research has declined by almost half in the past decade. In both North America and Europe, new approaches include greater governmental emphasis on problem-oriented projects than on curiosity driven projects. Similarly, there are trends to encourage general expertise over excessive specialization, to encourage more physician-scientist and basic scientist partnerships, and to make multidisciplinary approaches a funding priority.
In Canada, the administrative infrastructure for research has recently been reorganized into a Canadian Institutes of Health Research with 13 separate institutes. Within these there is a new focus on training programs to expand research capacity, and greater priority is given to approaches involving translational research and multidisciplinary approaches. One example of this shift in approach is the problem-oriented focus within the Canadian Institute of Human Development, Child and Youth Health. This new focus recently led to a series of physician-scientist workshops entitled 'The Child with Neurologic Impairment' that were designed to identify future directions for translational research in this area.
In New Zealand and Australia, the scope of the physicianscientist problem is similar to that in the US. New approaches there include efforts to increase the financial security of clinical researchers and to separate faculty salary support from research grants. In contrast, the scope of the physician-scientist problem is much less pronounced in Sweden and Denmark. In these countries, governmental institutions sponsor multiple clinical research institutes, such as the Karloinska Institute, that focus on excellence in 'translational research.' Perhaps more importantly, in most Scandanavian medical education programs, the MD degree is a prerequisite for PhD training. In this system, all researchers have a strong clinical background that naturally optimizes the rate of transfer of basic science findings into the clinical arena. In light of impressive Scandanavian success in translational research, strategies to improve the research competence of all MDs is now being carefully considered in numerous programs, as evidenced by the rising number of MD/PhD programs in major US medical schools. A key realization here, is that the character and content of the research training should be introduced as early as possible, maintained throughout the academic medical career, and progressively adapted to the challenges inherent at each stage of professional development.
Research development: medical students Although medical students are selected in large part on the basis of their ability to organize rather than to create, many are attracted to and participate in research, particularly as a summer elective. After graduation from medical school, however, there are many disincentives to research. First among these is the typical debt on graduation, which can be as much as $150, 000 or more. This debt, when measured against academic salaries that are generally far less than those in private practice, is a major obstacle to enthusiasm for fellowship research training, particularly when the duration of this training adds multiple low-income years to the training cycle. To counteract these influences, medical student education needs to cultivate appreciation of the importance of hypothesis-driven clinical research before graduation from medical school through well-publicized summer research fellowships. Quality and excellence in research performed by medical students needs to be recognized through established awards that confer prestige. Creation of small research grants for which only medical students could compete, would also provide valuable grant-writing experience. And finally, current education loan forgiveness programs must be expanded to include a broad variety of medical research training activities.
Research development: resident physicians
Despite the recent implementation of 80 h-per-week work limits for resident physicians, most residents are typically overburdened and have little time available for research. In addition, residents often have little knowledge of how to design or conduct clinical trials, and what is necessary to prepare a competitive research application. This deficit is a natural result of the low priority and limited time assigned to resident research in many resident training programs. To reverse these trends, greater support needs to be established to encourage residents to work with physicianscientists on clinical trials. As for medical students, a school administered system of awards and recognition for excellence in resident research would be an effective motivational tool. To this end, greater collaboration between residency programs and professional societies could help strengthen residency research standards, opportunities, and publication requirements. Finally, many more talented residents would be attracted to research if the fellowship salaries were competitive or superior to average resident salaries. Money does make a difference, particularly at this stage of career.
Research development: junior medical faculty New faculty members in clinical departments represent a major opportunity for building clinical research programs. Unfortunately, many of these promising physician-scientists experience difficulty securing funding despite excellent training and qualifications. One possible reason for this is that many junior medical faculty disregard clinically oriented research projects that can be difficult to publish or get funded, and instead focus on basic science approaches when starting a research program. Unfortunately, during their resident years many of these junior faculty have lost touch with major research developments outside their immediate areas and are ill-prepared to compete head-on with full-time basic scientists. To combat these trends, it will be important to significantly expand the amount and diversity of funds available to support new clinical research programs. For example, increases in the number of individual and institutional K awards would dramatically incentivize research; all opportunities and avenues to encourage such increases by NIH should be energetically pursued. Separate lines of both intramural and extramural funding focusing primarily on translational clinical research could be established. Ideally, projects funded by these sources would have as prerequisites both clinical and basic scientists, and perhaps also some means to support research by resident physicians. Such projects could be further strengthened if they were evaluated by a separate system of review designated only for grants focusing on translational research. In parallel, cultivation of translational research programs would be greatly facilitated by the establishment of new peer-reviewed journals, sponsored perhaps by key professional societies, which focus on publication of highquality clinical research. Collaboration between government institutions and professional societies could also strengthen clinical research through frequent sponsorship of workshops at professional society meetings to identify key research developments and opportunities and provide education about the funding process. This approach has recently been successful for the NINDS working in unison with the Child Neurological Society and other professional societies.
Research development: mid-career clinical faculty Across all specialties and stages of career development, a main obstacle to research success is the limited time available for research. At no career stage is this more challenging than for midcareer faculty who must find time to maintain both clinical and research competence. The investment of time in research is also often discouraged by highly competitive grant funding systems, by very low rates of reimbursement for time spent in research, and by the limited value placed on research as a criterion for professional advancement in many institutions. To counteract these potent influences, clinical research grants need to allow greater allocations for secretarial support to handle both research-related and patient-related paperwork; a minute saved managing patients is a minute found for research. As stated above, research by mid-career clinical faculty would also be greatly facilitated if funding institutions were to establish separate review processes for grants involving translational clinical research, with high priority given to multidisciplinary programs including both clinical and basic scientists. Similarly, reimbursement rates for time spent in research should become competitive with, or superior to, typical physician salaries. Research prestige could be enhanced through awards or prizes designed to recognize excellence in clinical research. New talent could be attracted to clinical research projects by creation of targeted awards to fund PhD students to work on projects related to clinical research. Research sponsors, both governmental and private, could also help diversify the clinical research enterprise by placing greater emphasis on the number of funded investigators rather than the number of funded applications.
Research development: late-career clinical faculty Although often overlooked as a source of research workforce, many late career faculty begin to lose interest in routine clinical practice and are amenable to new challenges as their responsibilities lighten. Early retirement of these faculty constitutes a loss of clinical expertise and perspective that could be well invested in numerous research programs. At a low level of involvement, senior faculty can support clinical research by providing access to established patient populations. At much higher levels of involvement, many of these faculty are capable of serving as coinvestigators or even as full-time principal investigators for a broad variety of clinical research protocols. To facilitate such involvement, new funding mechanisms are needed to support clinical research sabbaticals for senior faculty. Similarly, careerenrichment awards are needed for highly experienced clinicians wishing to develop contemporary research skills. The creative design of research programs that blend the extensive experience of senior faculty with the energy and enthusiasm of residents and young faculty would not only enhance research productivity, but could also help sustain a vigorous academic environment conducive to teamwork and esprit de corps.
Summary
The current scientific climate offers numerous exciting new technologies with unprecedented potential for enhancing understanding of many different pathophysiologies relevant to NICU patients. However, the pace of progress in translating these promising research opportunities into new strategies for clinical management is limited primarily by the number of trained physician-scientists. This challenge has been recognized in virtually all industrialized countries with advanced health care systems, and multiple possible remedies have been initiated. Most important among these is the strategy to build interest in, and enthusiasm for, translational research by emphasizing research training at all levels of career development. At the medical student level, strategies to couple educational debt reduction to research commitment and activity appear promising, as do efforts to create research opportunities and awards conferring prestige and recognition for student research excellence. For resident physicians, increasing the protected time allocated to research, improving training for the design and management of clinical protocols, expansion of institutional and governmental resources earmarked for resident research, improvement of fellowship salaries, and strengthened residency research requirements are all strategies in progress. For junior medical faculty, establishment of separate funding sources and review processes for clinical investigation, together with organization of more frequent clinical research workshops at society meetings, appear promising. For mid-career clinical faculty, the most important strategy is simply to increase the time available for research. This improvement, together with elevation of research salaries to levels competitive with those for practitioners and greater institutional support for, and recognition of research excellence, is particularly promising. For late-career clinical faculty, the goal here is retention of experienced faculty by providing an opportunity for them to make a highly respected contribution to research and teaching through either creation of senior clinical sabbatical fellowships, or late-career development awards. Creative and imaginative incorporation of these and other ideas throughout the medical education enterprise offer great promise not only to expand the current numbers of highly motivated physician-scientists, but also to stimulate many exciting advances and improvements in medicine.
